Marijuana legalization and opioid deaths

Area of Science:

• Public Health
• Epidemiology
• Substance Use Research

Background:

• Marijuana legalization has expanded across US states for medical and recreational use over the past two decades.
• Opioid-involved overdose deaths have significantly increased during the same period, creating a public health crisis.
• Previous research on the relationship between marijuana policies and opioid mortality has yielded inconsistent findings.

Purpose of the Study:

• To re-evaluate the association between marijuana legalization policies and opioid overdose death rates.
• To investigate whether the type of marijuana availability (medical vs. recreational, retail vs. non-retail) influences opioid mortality.
• To identify potential mechanisms linking cannabis legalization to opioid-related harms.

Main Methods:

• Replication and extension of previous empirical studies on marijuana legalization and opioid deaths.
• Analysis of state-level data, considering different policy specifications and time periods.
• Estimation of the association between legal medical and recreational marijuana availability, particularly through retail dispensaries, and opioid mortality rates.

Main Results:

• Prior empirical findings on marijuana legalization's effect on opioid deaths were often fragile and potentially overestimated protective effects.
• Legal medical marijuana, especially via retail dispensaries, showed an association with increased opioid mortality.
• Recreational marijuana sales, while less reliably estimated, also suggested a correlation with higher death rates.

Conclusions:

• The relationship between marijuana legalization and opioid overdose deaths is complex and requires careful empirical scrutiny.
• Retail availability of legal cannabis, both medical and recreational, may be associated with adverse trends in opioid mortality.
• The rise of illicit fentanyl may exacerbate the risks associated with cannabis legalization, potentially influencing opioid consumption patterns.